254 related articles for article (PubMed ID: 20163495)
1. Pharmacological activation of IKr impairs conduction in guinea pig hearts.
Larsen AP; Olesen SP; Grunnet M; Poelzing S
J Cardiovasc Electrophysiol; 2010 Aug; 21(8):923-9. PubMed ID: 20163495
[TBL] [Abstract][Full Text] [Related]
2. Use-dependent modulation of myocardial conduction by a new class of HERG agonists: deal breaker or cherry on top?
Akar FG
J Cardiovasc Electrophysiol; 2010 Aug; 21(8):930-2. PubMed ID: 20367661
[No Abstract] [Full Text] [Related]
3. In vivo effects of the IKr agonist NS3623 on cardiac electrophysiology of the guinea pig.
Hansen RS; Olesen SP; Rønn LC; Grunnet M
J Cardiovasc Pharmacol; 2008 Jul; 52(1):35-41. PubMed ID: 18594476
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological activation of rapid delayed rectifier potassium current suppresses bradycardia-induced triggered activity in the isolated guinea pig heart.
Hansen RS; Olesen SP; Grunnet M
J Pharmacol Exp Ther; 2007 Jun; 321(3):996-1002. PubMed ID: 17325228
[TBL] [Abstract][Full Text] [Related]
5. Iloperidone (Fanapt®), a novel atypical antipsychotic, is a potent HERG blocker and delays cardiac ventricular repolarization at clinically relevant concentration.
Vigneault P; Pilote S; Patoine D; Simard C; Drolet B
Pharmacol Res; 2012 Jul; 66(1):60-5. PubMed ID: 22465688
[TBL] [Abstract][Full Text] [Related]
6. An examination of the cardiac actions of PD117,302, a κ-opioid receptor agonist.
Pugsley MK; Saint DA; Hayes ES; Abraham S; Walker MJ
Eur J Pharmacol; 2015 Aug; 761():330-40. PubMed ID: 26086860
[TBL] [Abstract][Full Text] [Related]
7. A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias.
Belardinelli L; Liu G; Smith-Maxwell C; Wang WQ; El-Bizri N; Hirakawa R; Karpinski S; Li CH; Hu L; Li XJ; Crumb W; Wu L; Koltun D; Zablocki J; Yao L; Dhalla AK; Rajamani S; Shryock JC
J Pharmacol Exp Ther; 2013 Jan; 344(1):23-32. PubMed ID: 23010360
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms underlying increased right ventricular conduction sensitivity to flecainide challenge.
Veeraraghavan R; Poelzing S
Cardiovasc Res; 2008 Mar; 77(4):749-56. PubMed ID: 18056761
[TBL] [Abstract][Full Text] [Related]
9. Biophysical characterization of the new human ether-a-go-go-related gene channel opener NS3623 [N-(4-bromo-2-(1H-tetrazol-5-yl)-phenyl)-N'-(3'-trifluoromethylphenyl)urea].
Hansen RS; Diness TG; Christ T; Wettwer E; Ravens U; Olesen SP; Grunnet M
Mol Pharmacol; 2006 Oct; 70(4):1319-29. PubMed ID: 16825484
[TBL] [Abstract][Full Text] [Related]
10. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
[TBL] [Abstract][Full Text] [Related]
11. [HERG K+ channel, the target of anti-arrhythmias drugs].
Guan FY; Yang SJ
Yao Xue Xue Bao; 2007 Jul; 42(7):687-91. PubMed ID: 17882949
[TBL] [Abstract][Full Text] [Related]
12. Antiarrhythmic effect of IKr activation in a cellular model of LQT3.
Diness JG; Hansen RS; Nissen JD; Jespersen T; Grunnet M
Heart Rhythm; 2009 Jan; 6(1):100-6. PubMed ID: 19121808
[TBL] [Abstract][Full Text] [Related]
13. Flecainide attenuates rate adaptation of ventricular repolarization in guinea-pig heart.
Osadchii OE
Scand Cardiovasc J; 2016; 50(1):28-35. PubMed ID: 26402340
[TBL] [Abstract][Full Text] [Related]
14. The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applications.
Thomas D; Karle CA; Kiehn J
Curr Pharm Des; 2006; 12(18):2271-83. PubMed ID: 16787254
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological removal of human ether-à-go-go-related gene potassium channel inactivation by 3-nitro-N-(4-phenoxyphenyl) benzamide (ICA-105574).
Gerlach AC; Stoehr SJ; Castle NA
Mol Pharmacol; 2010 Jan; 77(1):58-68. PubMed ID: 19805508
[TBL] [Abstract][Full Text] [Related]
16. The hERG channel activator, RPR260243, enhances protective
Shi YP; Pang Z; Venkateshappa R; Gunawan M; Kemp J; Truong E; Chang C; Lin E; Shafaattalab S; Faizi S; Rayani K; Tibbits GF; Claydon VE; Claydon TW
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H251-H261. PubMed ID: 32559136
[TBL] [Abstract][Full Text] [Related]
17. Acute effects of oestrogen on the guinea pig and human IKr channels and drug-induced prolongation of cardiac repolarization.
Kurokawa J; Tamagawa M; Harada N; Honda S; Bai CX; Nakaya H; Furukawa T
J Physiol; 2008 Jun; 586(12):2961-73. PubMed ID: 18440994
[TBL] [Abstract][Full Text] [Related]
18. Lengthening of cardiac repolarization in isolated guinea pigs hearts by sequential or concomitant administration of two IKr blockers.
Hreiche R; Plante I; Drolet B; Morissette P; Turgeon J
J Pharm Sci; 2011 Jun; 100(6):2469-81. PubMed ID: 21491454
[TBL] [Abstract][Full Text] [Related]
19. Potassium channel activators differentially modulate the effect of sodium channel blockade on cardiac conduction.
Veeraraghavan R; Larsen AP; Torres NS; Grunnet M; Poelzing S
Acta Physiol (Oxf); 2013 Feb; 207(2):280-9. PubMed ID: 22913299
[TBL] [Abstract][Full Text] [Related]
20. Activation of human ether-a-go-go-related gene potassium channels by the diphenylurea 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643).
Hansen RS; Diness TG; Christ T; Demnitz J; Ravens U; Olesen SP; Grunnet M
Mol Pharmacol; 2006 Jan; 69(1):266-77. PubMed ID: 16219910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
